SCHEMBL26136379

SCHEMBL26136379

COc1cc(C)ccc1-c1nnc(Cl)c2cnccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.37
ACHE P22303 2/20 0.36
KDR P35968 2/20 0.35
CYP17A1 P05093 2/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CRHR1 P34998 1/20 0.35
ALPL P05186 1/20 0.34
POLB P06746 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
BRD4 O60885 1/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
SCN9A Q15858 3/20 0.34
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108916 1.00 MAOA (0.37) MAOAACHEKDRCYP17A1CYP19A1
SCHEMBL30108760 0.95 MAOA (0.37) MAOAACHEKDRCYP17A1CYP19A1
SCHEMBL24379605 0.88 SCN9A (0.42) MAOACYP19A1ALPLSCN9AMAPK1
SCHEMBL29874759 0.88 SCN9A (0.42) MAOACYP19A1ALPLSCN9AMAPK1
SCHEMBL30108774 0.86 MAOA (0.36) MAOACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL28934436 0.85 ACHE (0.41) ACHECRHR1POLBSMN1; SMN2SCN9A
SCHEMBL31673746 0.85 MAOA (0.37) MAOAACHEKDRCYP17A1CRHR1
SCHEMBL26134941 0.85 MAOA (0.37) MAOAACHEKDRCYP17A1CYP19A1
SCHEMBL28934464 0.84 MAPT (0.40) ACHECRHR1POLBSMN1; SMN2MEN1
SCHEMBL24379596 0.83 SCN9A (0.40) MAOACYP17A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183943-A1 PYRIDO-[3,4-D]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 DERIVATIVES VENTUS THERAPEUTICS U.S., INC. (US) 2023-09-28 WO disclosed